Montelukast Biotech 4 mg, 5 mg, 10 mg Chewable tablets
PDF Leaflet Revision Date: 22 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma.
Dosage (summary)
Adults: 10 mg daily; 6-14 years: 5 mg daily; 2-5 years: 4 mg daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Aspirin
- NSAIDs
- Gemfibrozil
- Ritonavir
- Rifampicin
Contraindications
- Hypersensitivity to montelukast
- Children under 2 years
- Pregnancy
- Lactation
Common side effects
- Headache
- Dizziness
- Fatigue
- Abdominal pain
- Rash
Counselling Points
- Take daily in the evening
- Not a rescue medication
- Report neuropsychiatric symptoms
Serious warnings
- Not for acute asthma attacks
- Neuropsychiatric events
- Eosinophilia risk
Important Disclaimer
The Montelukast Biotech 4 mg, 5 mg, 10 mg Chewable tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
